PIPELINE

PIPELINE
REGIMEN
TRIAL
INDICATION
PARTNER
PHASE 1 PHASE 2 PIVOTAL

Pipeline

TAVO™

REGIMEN

TAVO™ +
Nivolumab

TRIAL

OMS-104
Phase 2 IST

INDICATION

Neoadjuvant Resectable Locally / Regionally
Advanced Melanoma

PARTNER

partner-image
PHASE 1 PHASE 2 PIVOTAL

REGIMEN

TAVO™ + Pembrolizumab

TRIAL

Phase 2 RCT

INDICATION

Neoadjuvant Resectable Locally / Regionally
Advanced Melanoma

PARTNER

partner-image
PHASE 1 PHASE 2 PIVOTAL

REGIMEN

TAVO™ + Pembrolizumab

TRIAL

KEYNOTE-695

INDICATION

Advanced Melanoma

PARTNER

partner-image
PHASE 1 PHASE 2 PIVOTAL

REGIMEN

TAVO™ + Pembrolizumab

TRIAL

KEYNOTE-890

INDICATION

Advanced Triple Negative
Breast Cancer (TNBC)

PARTNER

partner-image
PHASE 1 PHASE 2 PIVOTAL

Learn more about our current clinical trials.

LEARN MORE